Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... ClASsification criteria for Psoriatic ARthritis (CASPAR) for classification. People with psoriasis were identified from the computerized morbidity indices of 2 large UK general practices, ...
2009 NOV 24 ... skin diseases. The aim of this investigation was to study the neuronal contribution to psoriasis at the remission and exacerbation phases," scientists in Stockholm, Sweden report. ...
2009 NOV 23 ... provide an integrated review of efficacy and safety from adalimumab clinical trials in psoriasis," scientists in Waterloo, Canada report. "Pooled analyses were conducted ...
2009 NOV 23 ... treatment for female sexual arousal disorder, and an early stage treatment for psoriasis. For further information about NexMed, go to www.nexmed.com. Keywords: ...
2009 NOV 17 ... with FDA 510(k) clearances to market the XTRAC® laser system for the treatment of psoriasis, vitiligo, atopic dermatitis and leukoderma. The Company also develops and markets ...
2009 NOV 23 ... According to recent research from Halifax, Canada, "The use of biologic medications for psoriasis is a recent therapeutic advance. To review clinical and economic data for biologic ...
2009 NOV 24 ... New research, 'Increased HIF-1 alpha immunostaining in psoriasis compared to psoriasiform dermatitides,' is the subject of a report. According to a ...
2009 NOV 16 ... or photochemotherapy have a significant impact on the skin. Many skin diseases such as psoriasis, atopic dermatitis, or cutaneous T-cell lymphoma significantly improve by photo(chemo) ...
2009 NOV 16 ... study included 67 patients with RA and 4 patients with polyarthritis resembling RA and psoriasis treated with leflunomide. A77 1726 steady-state plasma concentrations were determined by ...
2009 NOV 16 ... Investigators publish new data in the report 'Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept.' "Patients with...
2009 NOV 16 ... phosphorylation of eIF4E in psoriatic skin. Biopsies were collected from patients with psoriasis. mRNA expression and protein levels of eIF4E were evaluated by quantitative reverse ...
2009 NOV 23 ... "The simple use of topical corticosteroids in the treatment of severe psoriasis is often inefficient and harmful. The first line of treatment in these cases is based on ...
2009 NOV 24 ... atopy patch testing and from the skin of patients with chronic AD, skin of patients with psoriasis, and healthy skin. CCR expression of epidermal DCs was studied by using flow cytometry, ...
2009 NOV 17 ... publish new data in the report 'Inverse relationship between contact allergy and psoriasis: results from a patient- and a population-based study.' "An inverse association ...
2009 NOV 23 ... Ortho Biotech's Stelara, the first interleukin (IL)-12/23 inhibitor to enter the psoriasis drug market in the U.S., is expected to change the prescribing habits of dermatologists ...
2009 NOV 23 ... to recent research published in the Journal of Cutaneous Medicine and Surgery, "Nail psoriasis is common among patients with plaque psoriasis or ...
2009 NOV 23 ... of myocardial infarction (MI) was higher in psoriatics than in patients without psoriasis, and whether major cardiovascular risk factors were associated with...
2009 NOV 23 ... Markham, Canada, "Although some data addressing the burden of illness associated with psoriasis and psoriatic arthritis (PSA) have been reported for American and European patient ...
